RESUMO
In experiments of treatment carried out on 39 patients with cardiac insufficiency with tachyarrhythmia for the partially synthetic, new heart glycoside 3',4'-dipropionyl helveticosol the following clinico-pharmacological data of efficacy were approximately established on an average: level of full efficacy 2.7 mg, daily coefficient of disappearing 40%, coefficient of enteral absorption 30%, daily maintenance dose intravenously 1.1 mg and orally 3.7 mg.
Assuntos
Glicosídeos Digitálicos/uso terapêutico , Adulto , Cardanolídeos/uso terapêutico , Ensaios Clínicos como Assunto , Glicosídeos Digitálicos/administração & dosagem , Avaliação de Medicamentos , Feminino , Insuficiência Cardíaca/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Taquicardia/tratamento farmacológicoAssuntos
Vacina Antirrábica/efeitos adversos , Adulto , Criança , Edema/etiologia , Encefalomielite Aguda Disseminada/tratamento farmacológico , Encefalomielite Aguda Disseminada/etiologia , Humanos , Hipersensibilidade Imediata/etiologia , Prednisolona/uso terapêutico , Choque Cardiogênico/etiologia , Taquicardia/etiologiaRESUMO
On the basis of experiences with haemophilics is reported on the significance and possible neurotic digestion of organic diseases. In 60 outpatients the reasons of the verbal causes evoking the false treatment are described. Insufficient and exaggerated informations can be maldigested in the same way. In the drawing test examples are given, the therapeutic demands are discussed.